0001209191-20-059079.txt : 20201118 0001209191-20-059079.hdr.sgml : 20201118 20201118161925 ACCESSION NUMBER: 0001209191-20-059079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meyer Colin John CENTRAL INDEX KEY: 0001662392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 201325331 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-16 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662392 Meyer Colin John 5320 LEGACY DRIVE PLANO TX 75024 0 1 0 0 Chief Research Officer Class A common stock 2020-11-16 4 C 0 18605 A 90605 D Class A common stock 2020-11-16 4 S 0 12174 170.4778 D 78431 D Class A common stock 2020-11-16 4 S 0 3824 171.3826 D 74607 D Class A common stock 2020-11-16 4 S 0 2207 172.6065 D 72400 D Class A common stock 2020-11-16 4 S 0 100 173.75 D 72300 D Class A common stock 2020-11-16 4 S 0 200 174.98 D 72100 D Class A common stock 2020-11-16 4 S 0 100 175.00 D 72000 D Class A common stock 2020-11-17 4 C 0 6395 A 78395 D Class A common stock 2020-11-17 4 S 0 2450 164.4439 D 75945 D Class A common stock 2020-11-17 4 S 0 1815 165.2463 D 74130 D Class A common stock 2020-11-17 4 S 0 1930 166.1364 D 72200 D Class A common stock 2020-11-17 4 S 0 200 170.59 D 72000 D Employee Stock Option (right to buy) 11.00 2020-11-16 4 M 0 18605 0.00 D 2026-05-25 Class B common stock 18605 95031 D Class B common stock 2020-11-16 4 M 0 18605 11.00 A Class A common stock 18605 78384 D Class B common stock 2020-11-16 4 C 0 18605 D Class A common stock 18605 59779 D Employee Stock Option (right to buy) 11.00 2020-11-17 4 M 0 6395 0.00 D 2026-05-25 Class B common stock 6395 88636 D Class B common stock 2020-11-17 4 M 0 6395 11.00 A Class A common stock 6395 66174 D Class B common stock 2020-11-17 4 C 0 6395 D Class A common stock 6395 59779 D The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $170.00 to $170.95. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $171.00 to $171.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $172.00 to $172.96. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $163.92 to $164.9050. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $164.93 to $165.57. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $166.03 to $166.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The options, representing a right to purchase a total of 113,636 shares, vested in sixteen equal quarterly installments beginning on August 25, 2016. /s/ Tracy Herson, attorney-in-fact 2020-11-18